Last update 21 Nov 2024

Lerodalcibep

Overview

Basic Info

Drug Type
Fusion protein
Synonyms
Target
Mechanism
PCSK9 inhibitors(Proprotein convertase subtilisin kexin type 9 inhibitors)
Inactive Indication-
Originator Organization
Inactive Organization-
Drug Highest PhasePhase 3
First Approval Date-
Regulation-
Login to view timeline

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
ArteriosclerosisPhase 3
NO
03 Dec 2020
ArteriosclerosisPhase 3
IN
03 Dec 2020
ArteriosclerosisPhase 3
TR
03 Dec 2020
ArteriosclerosisPhase 3
IL
03 Dec 2020
Homozygous familial hypercholesterolemiaPhase 3
IN
07 Dec 2019
Homozygous familial hypercholesterolemiaPhase 3
US
07 Dec 2019
Homozygous familial hypercholesterolemiaPhase 3
IL
07 Dec 2019
Homozygous familial hypercholesterolemiaPhase 3
ZA
07 Dec 2019
Homozygous familial hypercholesterolemiaPhase 3
NO
07 Dec 2019
Homozygous familial hypercholesterolemiaPhase 3
TR
07 Dec 2019
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
166
Lerodalcibep 300 mg monthly
(tknihoxvxn) = yxdbeaarsj lgbotmmlln (zdhkbupwld )
Positive
29 May 2024
Inclisiran 284 mg on Day 1 and 90
(tknihoxvxn) = chzuvwoxrt lgbotmmlln (zdhkbupwld )
Phase 3
922
(dortmddqnf) = ksxopgygfk olpqzytrss (lwcebvpajc )
Met
Positive
29 May 2024
Placebo
(lyxtmfyatu) = scawoflvpj oimvsedyqk (pbblplhtck )
Phase 3
922
(eozavsfiso) = txwtepgqpb ktawdlbayh (frwkinrhii )
Met
Positive
08 Apr 2024
Phase 3
421
(kccddxctoz) = rzlvkgcqvh ygrkyhiuyg (fbewlujdxp )
Positive
07 Apr 2024
Phase 3
478
(nrulylqhxb) = ieniowhckg veebzcdxop (kmzwfxztjg )
Positive
28 Aug 2023
placebo
(nrulylqhxb) = vnfzlbcrrt veebzcdxop (kmzwfxztjg )
Phase 2
32
(ivjfgfbtoq) = LIB was well tolerated with all AEs considered mild and not drug related. Injection site reactions were minimal and considered mild when present. fmssvamepw (ivhwddhmyf )
Positive
11 Nov 2019
Placebo
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free